Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female participants willing to minimize the risk of inducing pregnancy for the duration of the clinical study and follow-up period (at least 10 weeks after study intervention).
You may not be if
Known immunization or hypersensitivity to any botulinum neurotoxin serotype
Any medical condition that may put the participant at increased risk with exposure to AGN-151586, including diagnosed myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or any other condition that might interfere with neuromuscular function
Marked facial asymmetry, dermatochalasis, deep dermal scarring, excessively thick sebaceous skin, or the inability to substantially lessen facial lines even by physically spreading them apart, as determined by the investigator
Any brow or eyelid ptosis, as determined by the investigator
Infection or skin disorder at the injection sites
History of facial nerve palsy
Any uncontrolled systemic disease
Anticipated need for treatment with botulinum neurotoxin of any serotype for any reason during the study (other than study intervention)
Anticipated need for surgery or overnight hospitalization during the study
Prior periorbital surgery, facial lift (full face or mid-face), thread lift, brow lift, or related procedures (eg, eyelid \[blepharoplasty\] and/or eyebrow surgery)
